Search This Blog

Friday, February 16, 2024

Alnylam Pharmaceuticals, Inc.: Goldman Sachs downgrades to neutral from buy

  price target reduced from USD 230 to USD 173.

https://www.marketscreener.com/quote/stock/ALNYLAM-PHARMACEUTICALS-I-8322/

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)